Human immunodeficiency virus (HIV)-infected patients have excellent outcomes following kidney transplantation (KT) but still might face barriers in the evaluation and listing process. The aim of this study was to characterize the patient population, referral patterns, and outcomes of HIV-infected patients who present for KT evaluation.
| INTRODUCTION
After the introduction of combination anti-retroviral therapy (cART),
the human immunodeficiency virus (HIV) epidemic in the United
States has transformed from one of acute and devastatingly high mortality to one of a chronic disease. 1 Despite this advancement, many chronic comorbid conditions burden the lives of HIV-infected patients. Among these comorbid conditions, chronic kidney disease is quite prevalent. [2] [3] [4] For those who progress to end-stage renal disease (ESRD), mortality is higher in HIV-infected patients than in their uninfected counterparts. 5, 6 Kidney transplantation (KT) has emerged as an effective and preferred alternative to dialysis in HIV-infected patients with ESRD with outcomes that are similar to those of the uninfected population. [7] [8] [9] [10] Given these excellent outcomes, KT for HIV-infected patients has increased 42-fold between 2000 and 2014. 7 The HIV Organ Policy
Equity (HOPE) Act recently legalized the use of HIV-infected organs
for transplantation into HIV-infected patients to expand the donor pool for KT in the HIV-infected population as well as to mitigate organ shortages for the general population.
11,12
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Despite advances in KT for HIV-infected patients, data are few on the KT evaluation and listing process, including how it might differ from that of the general population. Given the potential benefits of KT for HIV-infected patients with ESRD, and to facilitate centers to optimally take advantage of the expansion of the donor pool through the HOPE Act, in this study we examined potentially modifiable barriers to transplantation by assessing outcomes of the evaluation and listing process for HIV-infected patients referred to our transplant center.
| METHODS

| Study design
We performed a retrospective cohort study of HIV-infected patients referred for KT to Hahnemann University Hospital (Philadelphia, PA, USA). Patients were included in the study if they were >18 years of age, and were HIV positive when evaluated for KT at our center be- 
| Outcomes
The primary outcome for this study was listing for KT (either active or inactive status 
| Covariates
We used the electronic medical record to assess baseline demographic information (ie, age, gender, race/ethnicity, employment status) and medical history. Medical history included common comorbidities (eg, hypertension, diabetes, chronic hepatitis B and C infection), cause of kidney disease, receipt and modality of dialysis, and history of alcohol or drug abuse. HIV history was abstracted from the HIV treatment providers' records and included cART regimen, history of OIs, mode of HIV transmission, CD4 count (cells/mL), VL (copies/mL), and presence of resistance mutations.
To ascertain referral mechanisms, we reviewed the selfdocumented intake form from the initial transplant evaluation.
Referral sources were divided into six categories: (i) nephrologist, (ii) dialysis center, (iii) HIV provider, (iv) primary care provider, (v) selfreferral, or (vi) social worker. Time to transplant referral was defined as the time between the date of dialysis initiation and the date of KT evaluation.
| Statistical analysis
We 
| RESULTS
| Patient characteristics
During the study period, 105 HIV-infected patients were evaluated for KT at our center and included in our analysis ( Figure 1 ). Table 1 depicts demographics and characteristics. The median age was 
| Transplant evaluation referral patterns
More than half the cohort of HIV patients were referred by nephrologists or dialysis centers (n = 51, 57.3%), compared to only a small portion that were referred by either primary care or an HIV physician (n = 5, 5.6%).
The median time from start of dialysis date to evaluation at the transplant center was 24.6 months (IQR 4-63.8 months) (Figure 2 ).
| Transplant evaluation outcomes
Of the 105 HIV-infected patients evaluated for KT at our center over 4 years, 70% (n = 73) were ultimately deemed eligible for KT.
Of the patients who were deemed ineligible for KT, the most common reasons were active substance abuse (n = 7, 23%) and inability to complete the requirements of the transplant evaluation, which might include subspecialty evaluations, such as cardiology and hepatology (n = 7, 22.6%) (Figure 3 We observed that 50% of the HIV-infected patients deemed eligible for transplant (n = 35) experienced delayed time to listing (defined as >90 days). Reasons cited for delay were evaluation of non-compliance (n = 8; 27%), cardiac evaluation (n = 6; 20%), and insurance-related issues (n = 5; 17%) ( Figure 3 ). Ultimately, of the 105 patients evaluated, 10
patients received KT within the 4 years of the study (Figure 1 ).
| DISCUSSION
In 14 Of those who did not meet eligibility, the primary disqualifying factor was lack of CD4 and VL data at time of evaluation or evidence of uncontrolled HIV.
14 Interestingly, our study demonstrated a much higher rate of eligibility and fewer had uncontrolled HIV as a reason for ineligibility. This difference probably reflects many factors. First, dialysis providers may be more aware of listing criteria for KT than they were in the historical cohort, limiting the number of patients referred with detectable VLs. Also, the success we have had in listing HIV-infected patients might largely be driven by our on-site assessment by an infectious disease physician, who reviewed outpatient HIV management records during the initial visit. Other factors could be acquisition of CD4/VL on-site and improved HIV management owing to more effective and widely available ART. Our study was performed over a 4-year period, providing opportunities for persons who were initially not appropriate, which would also account for the higher rate of listing. Our study and that of Sawinski et al 14 had similar observations with respect to the significant proportion of patients who were ineligible for listing because of failure to complete the requisite work-up, including cardiology and hepatology evaluations. This suggests that the complexity of the evaluation process is still significantly burdensome for many HIV-infected patients despite advances in overall HIV management. The complexity of the evaluation process might also contribute to the relatively high proportion of delayed listings observed These findings highlight the last decade's advancements in overall HIV care, as well as the increased access to KT for HIV-infected ESRD patients. However, they also illustrate several areas in the KT evaluation process that require continued improvement. Failure to complete the requisite clinical work-up is a recurrent barrier to listing for KT. We propose that restructuring the evaluation system is a potential way to mitigate this barrier. This restructuring might be accomplished by having more subspecialty consultants on-site during the evaluation of comorbid conditions (eg, cardiology and hepatology), like how we have incorporated on-site infectious disease consultation. This change could be of particular value for hepatitis C virus co-infected patients, who had an even lower incidence of listing than mono-infected patients with only HIV. Co-infected patients often need a liver biopsy prior to listing and on-site hepatology consultation could streamline this process. Restructuring the evaluation system could also offer the potential to decrease the proportion of delayed listings.
T A B L E 1 Baseline demographics
It is well-documented that a direct relationship exists between dialysis vintage and mortality in ESRD patients, and this association may be exacerbated by the presence of HIV, with its related higher risks of infection and mortality from cardiovascular disease. 6, 13 Thus, it is imperative to promote timely referral for HIV-infected patients with ESRD for KT evaluation, and ideally before dialysis onset to maximize waiting time accrual. In our study population, HIV-positive kidney candidates were on dialysis for a median of 2 years before transplant referral. This finding is similar to an observation from a prior national study, where dialysis vintage was longer in HIV-infected patients than non-infected patients (2.5 years vs 0.8 years; P < .001). 15 Further, the majority of referrals in the study were generated from dialysis providers, with a minority from other providers, such as HIV care providers. This fact may highlight a need to educate HIV care providers and primary care physicians on the benefits of early referral for KT in HIV patients. We observed a significant difference between patients who were eligible for listing vs those who were not, based on access to their HIV care provider records (70.4% for listed patients vs 34.5%
for unlisted patients; P-value .007). This finding implies that consistent follow-up with a trained HIV care provider may be associated with higher rates of successful transplant listing. This finding also underlies our assertion that an urgent need exists for greater awareness of the implications of CKD and the process of KT referral among HIV care providers.
Although this study is one of few to describe the KT evaluation process in HIV-infected patients at a high-volume center, it has important limitations. First, it is a single-center study in an urban environment with a predominantly black, male population. Also, it is one of the highest-volume centers for HIV-infected KT in the United States.
These facts limit its generalizability to other centers and referral networks. In addition, this study was unable to capture data on patients who were referred, but did not present for evaluation, thus limiting our ability to comprehensively observe referral practices. We also only had access to the medical charts of HIV care providers for approximately 50% of the cohort (n = 56).
F I G U R E 3
Reasons for not eligible for listing and delay. Pt, patient; HIV, human immunodeficiency virus; GFR, glomerular filtration rate; Psy, psychiatric; Inc., incomplete; Heme/Onc, hematology/oncology; w/u, workup
